Clinical and Experimental Allergy

Papers
(The H4-Index of Clinical and Experimental Allergy is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Are paediatric allergy services promoting or harming public health?84
Eosinophil‐derived neurotoxin reference values in asthma: The way forward83
Optimal ImmunoCAP Aspergillus fumigatus ‐Specific I81
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy57
Cochrane corner: Pulmonary rehabilitation for adults with asthma50
Featured Cover39
Temporal Trends in the Course and Management of Chronic Urticaria at a European Tertiary Center38
Clustering of the Bronchial Epithelial Immune Response to Viral Stimulation in Patients With Asthma Identifies Clinically Recognisable Epithelial Exacerbation Response Profiles38
Association between long‐term occupational exposure to PM 10 and allergic diseases in subway workers35
Issue Information35
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab34
32
Nutritional disorders prevalence among adults with immunoglobin E‐mediated food allergy32
The Gap Between Prescription and Practice: Adrenaline Autoinjector Carriage in an Australian Cohort29
Atopic sensitization in childhood depends on the type of green area around the home in infancy27
Patients with piperacillin–tazobactam allergy labels tolerate other beta‐lactams27
Correction to “Prehospital Care in Fatal Food Anaphylaxis: A Nationally Representative Case Series”26
Poor head growth and developmental delay in infants with eczema, food allergies and growth faltering26
Recombinant T‐cell epitope conjugation: A new approach for Dermatophagoides hypoallergen design25
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series25
Anthropological and sociological perspectives on food allergy25
Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real‐World Study on Effectiveness and Safety in Dupilumab Nonresponders25
Ara h 2 105‐124 ‐Specific TH2A Cells Drive Peanut Allergy in DRB1*15:01 Individuals: A Detailed Epitope Analysis25
British Society for Allergy and Immunology (BSACI) Abstracts of the 2023 UK Conference (5–7 October, Harrogate Convention Centre, Harrogate, UK)24
Changes in sensitization rates for respiratory and food allergens by age24
24
0.67982220649719